Muromonab Cd3

Drug Index

Muromonab-CD3 (trade name Orthoclone OKT3, marketed by Janssen-Cilag) is an immunosuppressant drug given to reduce acute rejection in patients with organ transplants.[1][2] It is a monoclonal antibody targeted at the CD3 receptor,[3] a membrane protein on the surface of T cells. It was the first monoclonal antibody to be approved for clinical use in humans.[2] Contents 1 History 2 Indications 3 Pharmacodynamics and chemistry 4 ...

Muromonab-CD3

Muromonab-CD3 (trade name Orthoclone OKT3, marketed by Janssen-Cilag) is an immunosuppressant drug given to reduce acute rejection in patients with organ transplants.[1][2] It is a monoclonal antibody targeted at the CD3 receptor,[3] a membrane protein on the surface of T cells. It was the first monoclonal antibody to be approved for clinical use in humans.[2] Contents 1 History 2 Indications 3 Pharmacodynamics and chemistry 4 ...

NDC Database

Okt3 5 mg/5ml Intravenous Injection, Solution by Centocor Ortho Biotech Products, L.p. ## Package Codes: 59676-101-01 ## Active Ingredients: Muromonab-cd3